83 results
8-K
PVCT
Provectus Biopharmaceuticals, Inc.
16 Apr 24
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
4:58pm
, clinical operations, regulatory strategy and affairs, intellectual property, drug substance/product manufacturing, business/corporate development
8-K
EX-10.2
PVCT
Provectus Biopharmaceuticals, Inc.
16 Apr 24
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
4:58pm
, regulatory strategy and affairs, intellectual property, drug substance/product manufacturing, business/corporate development, and investor/publication
8-K
PVCT
Provectus Biopharmaceuticals, Inc.
26 Mar 24
Departure of Directors or Certain Officers
4:48pm
, intellectual property, regulatory strategy and affairs, drug substance and drug product formulation and manufacturing, business and corporate development
8-K
EX-10.2
l2csn pc1c
26 Mar 24
Departure of Directors or Certain Officers
4:48pm